advertisement
Kolko M 21
Showing records 1 to 21 | Display all abstracts from Kolko M121901 Glaucoma: now and beyond
Jayaram H
Lancet 2023; 402: 1788-1801
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Fineide F
Acta Ophthalmologica 2024; 102: 735-748
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Langbøl M
Cellular and molecular neurobiology 2024; 44: 59
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Rovelt J
Ophthalmology. Glaucoma 2024; 0:
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Saruhanian A
Cellular and molecular neurobiology 2024; 44: 59
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Freiberg J
Ophthalmology. Glaucoma 2024; 0:
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Magnø M
Acta Ophthalmologica 2024; 102: 735-748
121901 Glaucoma: now and beyond
Kolko M
Lancet 2023; 402: 1788-1801
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Azuara-Blanco A
Ophthalmology. Glaucoma 2024; 0:
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Dahlø K
Acta Ophthalmologica 2024; 102: 735-748
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Saruhanian S
Cellular and molecular neurobiology 2024; 44: 59
121901 Glaucoma: now and beyond
Friedman DS
Lancet 2023; 402: 1788-1801
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Virgili G
Ophthalmology. Glaucoma 2024; 0:
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Tiedemann D
Cellular and molecular neurobiology 2024; 44: 59
121901 Glaucoma: now and beyond
Gazzard G
Lancet 2023; 402: 1788-1801
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Kolko M; Heegaard S
Acta Ophthalmologica 2024; 102: 735-748
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Baskaran T
Cellular and molecular neurobiology 2024; 44: 59
122517 The Multifaceted Nongenetic Risk Factors for Primary Open-angle Glaucoma: An Overview of Systematic Reviews
Kolko M
Ophthalmology. Glaucoma 2024; 0:
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Vohra R
Cellular and molecular neurobiology 2024; 44: 59
119799 Topical glaucoma medications - Possible implications on the meibomian glands
Vehof J; Utheim TP
Acta Ophthalmologica 2024; 102: 735-748
119896 Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension
Rives AS; Moreira J; Prokosch V; Liu H; Lackmann JW; Müller S; Nielsen CH; Kolko M; Rovelt J
Cellular and molecular neurobiology 2024; 44: 59
